Clover Health Investments (CLOV) Tops Q4 EPS by 24c

Clover Health Investments (NASDAQ: CLOV) reported Q4 revenue for the quarter at $898.79 million versus the consensus estimate of $785.48 million.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Redwood Trust reports record Aspire quarter, launches AI pricing tools
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)